The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

about

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

Item

http://www.wikidata.org/entity/Q43116731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@en

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@nl

type

Item

label

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@en

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@nl

prefLabel

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@en

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.

@nl

P1476

The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent

@en

P2093

Cancan Wang

http://www.w3.org/2001/XMLSchema#string

Shuang Wu

http://www.w3.org/2001/XMLSchema#string

Shun Lei

http://www.w3.org/2001/XMLSchema#string

Xiong Xie

http://www.w3.org/2001/XMLSchema#string

Yao Ding

http://www.w3.org/2001/XMLSchema#string

Yun Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

Self-consumption: the interplay of autophagy and apoptosis

Cancer statistics, 2014

3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes

Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin.

Autophagy as a cell death and tumor suppressor mechanism.

BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.

The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent.

The role of autophagy in cancer development and response to therapy.

P304

e0184501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0184501

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Houjie Liang

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29065135

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5655484

http://www.w3.org/2001/XMLSchema#string